Driehaus Capital Management’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.55M | Buy |
535,464
+179,469
| +50% | +$519K | 0.01% | 342 |
|
|
2025
Q1 | $765K | Sell |
355,995
-913,861
| -72% | -$1.96M | 0.01% | 355 |
|
|
2024
Q4 | $4.91M | Sell |
1,269,856
-9,232
| -0.7% | -$35.7K | 0.04% | 294 |
|
|
2024
Q3 | $8.38M | Sell |
1,279,088
-35,018
| -3% | -$229K | 0.07% | 244 |
|
|
2024
Q2 | $9.53M | Buy |
1,314,106
+225,879
| +21% | +$1.64M | 0.09% | 223 |
|
|
2024
Q1 | $8.26M | Buy |
+1,088,227
| New | +$8.26M | 0.08% | 249 |
|
|
2022
Q4 | – | Sell |
-119,223
| Closed | -$382K | – | 383 |
|
|
2022
Q3 | $382K | Sell |
119,223
-91,277
| -43% | -$292K | 0.01% | 320 |
|
|
2022
Q2 | $413K | Hold |
210,500
| – | – | 0.01% | 313 |
|
|
2022
Q1 | $853K | Hold |
210,500
| – | – | 0.01% | 329 |
|
|
2021
Q4 | $2.27M | Hold |
210,500
| – | – | 0.02% | 301 |
|
|
2021
Q3 | $2.43M | Hold |
210,500
| – | – | 0.03% | 316 |
|
|
2021
Q2 | $2.07M | Hold |
210,500
| – | – | 0.03% | 311 |
|
|
2021
Q1 | $3.08M | Buy |
210,500
+100,000
| +90% | +$1.46M | 0.05% | 304 |
|
|
2020
Q4 | $2.37M | Buy |
110,500
+25,500
| +30% | +$546K | 0.04% | 283 |
|
|
2020
Q3 | $1.29M | Hold |
85,000
| – | – | 0.03% | 273 |
|
|
2020
Q2 | $1.09M | Buy |
+85,000
| New | +$1.09M | 0.03% | 282 |
|